当前位置: 首页 > 期刊 > 《中国医学创新》 > 2015年第28期
编号:12579964
复方托吡卡胺滴眼液在近视儿童散瞳验光中的应用效果(1)
http://www.100md.com 2015年10月5日 中国医学创新 2015年第28期
     【摘要】 目的:探讨复方托吡卡胺滴眼液在近视儿童屈光检查中的应用效果。方法:将56例(112只眼)7~17岁近视患者分为7~12岁组和13~17岁组,在散瞳前后,由有经验的验光师对患者进行电脑验光和检影验光,应用SPSS 17.0统计软件比较每组用药前后等效球镜(SE)值的变化。结果:每组散瞳前后SE值比较差异均无统计学意义(P>0.05)。结论:复方托吡卡胺滴眼液是一种睫状肌麻痹剂,但对不同年龄的儿童睫状肌麻痹作用效果有限,且散瞳前后屈光度无明显变化。

    【关键词】 复方托吡卡胺; 近视; 儿童

    【Abstract】 Objective:To study the effect of the applying of compound tropicamide eye drops in refractive inspection of children with myopia.Method:56 cases(112 eyes)myopia children aged from 7 to 17 years were grouped as group 7-12 years and 13-18 years.The refractive capacity of the eye was examined with a computer and a retinoscopy by skilled optometrist before and after mydriasis. The differences of the values of spherical equivalence(SE)before and after mydriasis were analyzed with SPSS 17.0 in every group.Result:There were no significant differences in the values of SE before and after mydriasis in each group(P>0.05).Conclusion:Compound tropicamide eye drops is a cycloplegic agent. But its effects are limited for children with different age. ......
1 2 3下一页

您现在查看是摘要页,全文长 3774 字符